3WHO. Resurgence of Wild poliovirus types 1 and 3 in 15 African countries, January 2000-March 2009 [J ] .WER, 2009, 84 (16) : 133-140.
4Kew O, Morris-Glasgow V, Landaverde M, et al. Outbreak of poliomyelitis in Hispaniola associated with circulating typel vaccinederived poliovirus [J]. Science, 2002, 296(5566): 356-359.
5Yang CF, Naguib T, Yang S J, et al. Circulation of endemic type 2 vaccine-derived polio virus in Egypt from 1983 to 1993[J]. J Virol, 2003.77 ( 15 ): 8366-8377.
6Shimizu H, Thorley B, Paladin F J, et al. Circulation of type 1 vaccine-derived poliovirus in the Philippines in2001 [J]. J Virol, 2004,78(24): 13512-13521.
7Rousset D, Rakoto-Andrianarivelo M, Razafindratsimandresy R, et al. Recombinant vaccine-derived poliovirus in Madagascar[J]. Emerg Infect Dis, 2003, 9(7 ): 885-887.
8Kew OM, Sutter RW, de Gourville EM, et al. Vaccine derived poliovirus and the endgame strategy for global polio eradication [J]. Annu Rev Microbiol, 2005, 59: 587-635.
10Balanant J, Ouillot S, Candrea A, et al. The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay [ J ] .Virology, 1991,184 ( 2 ) : 645-654.
